Antimicrob Agents Chemother

1. PETERSIEL N, Howden BP, Giulieri S, Tong SYC, et al
   An Achilles' heel for methicillin-resistant Staphylococcus aureus? Re-evaluating beta-lactam susceptibility of MRSA.
   Antimicrob Agents Chemother. 2026 Jul 6:e0037426. doi: 10.1128/aac.00374.
   

   >> Share

   
   
2. LIU H, Huang X, Li X, Li Y, et al
   A genomic framework for tracking antibiotic resistance genes: global dissemination of cfr-family genes.
   Antimicrob Agents Chemother. 2026 Jul 10:e0012226. doi: 10.1128/aac.00122.
   

   >> Share

   
   
3. MALLECOT E, Berti V, Petitjean M, Meyer J, et al
   Influence of iron uptake systems on cefiderocol activity in Escherichia coli: At the crossroads of antibiotic resistance and virulence.
   Antimicrob Agents Chemother. 2026 Jul 10:e0167925. doi: 10.1128/aac.01679.
   

   >> Share

   
   

   
   Clin Infect Dis

4. MARTIN MA, Blenkinsop A, Moffa M, Reynolds SJ, et al
   Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study.
   Clin Infect Dis. 2026 Mar 13:ciag161. doi: 10.1093.
   

   >> Share

   
   
5. MAZZITELLI M, Parczewski M, Burger D, Wensing A, et al
   Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications.
   Clin Infect Dis. 2026 Mar 11:ciag046. doi: 10.1093.
   

   >> Share

   
   
6. CANTON R, Lim AN, Cortes V, Diaz-Reganon J, et al
   Uncomplicated Urinary Tract Infections: From an Invisible Impact to a Visible Change in Complex Care.
   Clin Infect Dis. 2026 Feb 25:ciaf705. doi: 10.1093.
   

   >> Share

   
   
7. MAKINSON A, Bani-Sadr F, Palich R, Montes B, et al
   Switch to BIC/TAF/FTC or DTG + TDF/FTC in virologically suppressed PWH: outcomes in real-world setting with and without tenofovir resistance.
   Clin Infect Dis. 2026 Jan 9:ciaf726. doi: 10.1093.
   

   >> Share

   
   
8. CROSS GB, Walker HN, Hasan T, Berry C, et al
   We Are Underprepared for Bedaquiline Resistance: A Call for Clinical and Programmatic Readiness.
   Clin Infect Dis. 2026;82:e1326-e1332.
   

   >> Share

   
   
9. BERCOT B, Assoumou L, Camelena F, Voitichouk C, et al
   Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.
   Clin Infect Dis. 2025 Nov 10:ciaf591. doi: 10.1093.
   

   >> Share

   
   

   
   Int J Antimicrob Agents

10. MULDER D, van de Schootbrugge-Vandermeer HJ, Sun D, van Duuren LA, et al
    The Association between Antibiotic Consumption and Antimicrobial Resistance-Related Mortality and Costs: an Analysis of European Country-level Data.
    Int J Antimicrob Agents. 2026 Jul 6:107903.
    

    >> Share

    
    

    
    J Antimicrob Chemother

11. VICKERS A, Day M, Doumith M, Vivekanand S, et al
    Improved molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae in a reference laboratory setting.
    J Antimicrob Chemother. 2026;81:dkag211.
    

    >> Share

    
    

    
    J Clin Microbiol

12. NOTARTE KI, Allen K, Armstrong DT, Parrish N, et al
    Evaluation of the deeplex Myc-TB-targeted next-generation sequencing assay for mycobacterial identification and drug resistance detection.
    J Clin Microbiol. 2026;64:e0008226.
    

    >> Share

    
    
13. KAPLE CE, Cadnum JL, Redmond SN, Jencson AL, et al
    A sensitive and reduced-cost culture medium for recovery of Clostridioides difficile isolates with reduced fidaxomicin susceptibility from stool.
    J Clin Microbiol. 2026;64:e0006826.
    

    >> Share

    
    
14. MCTAGGART LR, Eshaghi A, Cronin K, Patel SN, et al
    Post-pandemic surge of Mycoplasma pneumoniae in Ontario, 2024: molecular surveillance and resistance trends relative to 2018-2023.
    J Clin Microbiol. 2026;64:e0018826.
    

    >> Share

    
    
15. GEFROH SJ, Meier BM, Bowden RR, Evans DR, et al
    Evaluating veterinary Staphylococcus beta-lactam breakpoint performance: a comparative analysis of individual agents versus oxacillin as a surrogate.
    J Clin Microbiol. 2026 Jun 12:e0016826. doi: 10.1128/jcm.00168.
    

    >> Share

    
    
16. KUSS-DUERKOP SK, Godo P, DeCurtis EK, Pham V, et al
    Performance of a targeted next generation sequencing assay for mycobacterial identification and drug resistance from sputum and isolates.
    J Clin Microbiol. 2026;64:e0010626.
    

    >> Share

    
    

    
    J Infect Dis

17. MELENDEZ JH, Onzia AA, Mande E, Tirado AM, et al
    Pharyngeal gonorrhea in Ugandan men with urogenital gonorrhea: differences in antimicrobial resistance and strain types between anatomical sites.
    J Infect Dis. 2026 Jul 8:jiag353. doi: 10.1093.
    

    >> Share

    
    
18. WAN T, Lautenbach E, Mannathoko N, Mosepele M, et al
    Diverse genetic lineages spreading across healthcare and community boundaries underlie extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) colonization burden in Botswana.
    J Infect Dis. 2026 Jul 7:jiag342. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Microbiol

19. YE J, Ye K, Lu Y, Qiu R, et al
    Integrated clinical and genomic characterization of Acinetobacter baumannii causing bloodstream infections in a Chinese tertiary hospital.
    J Med Microbiol. 2026;75:002177.
    

    >> Share

    
    

    
    Lancet

20. DEZZA FC, Pulido LB, Borreguero IB, Perez FD, et al
    Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTE): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.
    Lancet. 2026 Jul 9:S0140-6736(26)00760-9. doi: 10.1016/S0140-6736(26)00760.
    

    >> Share

    
    

    
    Nature

21. GORDZEVICH R, Xu M, Wang W, Cook MA, et al
    A Streptomyces megacluster encodes synergistic biotin-targeting antibiotics.
    Nature. 2026;655:478-486.
    

    >> Share

    
    

    
    PLoS Biol

22. MACLEAN RC, Mulkern A, Shaw LP
    Resistance potentiators: Evolutionary catalysts of antibiotic resistance.
    PLoS Biol. 2026;24:e3003852.
    

    >> Share

    
    

    
    PLoS One

23. THANKAMANI A, C L B, Doss C GP
    Machine learning-based analysis of drug resistance mutations in Mycobacterium tuberculosis.
    PLoS One. 2026;21:e0352863.
    

    >> Share

    
    
24. MARTIN MM, Martin HD, Lyimo BM
    Prevalence, virulence profiles and antibiotic susceptibility patterns of Shiga toxin producing Escherichia coli O157:H7 among children 6-59 months in Longido, Arusha-Tanzania.
    PLoS One. 2026;21:e0353396.
    

    >> Share

    
    
25. MITIKU A, Manilal A, Asnake E, Hussien B, et al
    Sepsis neonatorum: Bacterial profile, antimicrobial resistance patterns, among neonates and associated factors, Dilla University Referral Hospital, southern Ethiopia, with special reference to WHO prioritized pathogens.
    PLoS One. 2026;21:e0352190.
    

    >> Share

    
    
26. B ALHUSSEINI L, Nabeeh Jaafar F, R Alsharmani A, Kouhsari E, et al
    In silico antimicrobial resistance profiling of 1,240 Stenotrophomonas maltophilia genomes: AMR gene prevalence, temporal evolution, and ST-specific associations.
    PLoS One. 2026;21:e0350669.
    

    >> Share

    
    
27. SANTOS-LAZARO D, Vigo AN, Cotrina VV, Villar S, et al
    Genetic surveillance of first- and second-line drug-resistant isolates of Mycobacterium tuberculosis in Peru.
    PLoS One. 2026;21:e0352881.
    

    >> Share

    
    
28. SIDIQ Z, Anand A, Dwivedi KK, Tyagi P, et al
    Diagnostic accuracy, operational feasibility, and cost considerations of Truenat MTB Plus and Xpert MTB/RIF Ultra for pulmonary tuberculosis.
    PLoS One. 2026;21:e0341988.
    

    >> Share

    
    
29. RUAN L, Fan C, Chen J, Wang Y, et al
    A novel COE-D8-fosfomycin conjugate effectively combats first-line antibiotic-resistant uropathogenic Escherichia coli.
    PLoS One. 2026;21:e0352997.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share